“Through this combination, Numira will be better positioned to deliver more complete solutions and a broader range of leading-edge imaging products for the drug discovery research market,” said Michael Beeuwsaert, president and CEO, Numira Biosciences.
Visual Influence will remain in Salt Lake City and its president, David Weinstein, will become Numira’s chief technology officer. Numira is a specialty research and development tools company focused on leveraging advances in genetics and molecular imaging.
“We look forward to developing a number of powerful, integrated products that leverage Numira’s novel targeted reagent technologies with our visualization software capabilities,” said Dr David Weinstein.